Navigation Links
Sentrx Exits 2008 with Strong Growth

Sentrx, a New Jersey drug safety specialty firm, announced today that the company grew the number of pharmacovigilance outsourcing contracts by more than 50% in 2008. Revenues for the year increased 25% over 2007. The domestic service provider added long-term contracts in clinical trial and post-marketing safety, managed safety system hosting, and risk evaluation and mitigation strategies. The company maintained its strong record of regulatory compliance during this period of growth.

Little Falls, NJ (PRWEB) January 20, 2009 - Sentrx, the leading provider of drug safety services, announced today that the company grew the number of pharmacovigilance outsourcing contracts by more than 50% in 2008. Revenues for the year increased 25% over 2007.

Sentrx pioneered the concept of drug safety outsourcing and safety system hosting for clinical trials and post-marketed products in 1999. Since that time, Sentrx has provided operational and consulting services to nearly eighty unique clients. More than fifty of those companies have outsourced adverse event processing, safety system management, or risk evaluation and mitigation strategies (REMS) to Sentrx.

Sentrx provides services from its headquarters in Little Falls, NJ. In addition to a staff of office-based health care professionals, the company utilizes its network of highly experienced drug safety investigators across the United States. This flexible workforce allows Sentrx to handle volume fluctuations and extended coverage hours for its clients, which benefit from the quality, reliability and convenience of a domestic service provider.

Highlights of new business in 2008 include:

¨ Managed safety system hosting for seven biopharmaceutical companies and a large generic manufacturer
¨ Post-marketing safety surveillance for two specialty pharmaceutical companies
¨ Clinical trial safety monitoring for four biopharmaceutical companies
¨ REMS with Elements to Assure Safe Use for a biopharmaceutical company
¨ Safety system consulting engagements at three large companies
¨ Data migration projects at two specialty pharmaceutical companies
¨ Risk management plans authored and approved for two New Drug Applications
¨ Contract renewal and expansion with several existing clients

Other accomplishments in 2008 include:

¨ Installation of Phase Forward's Empirica™ Trace 4.2 in the Sentrx Hosting Center
¨ Implementation of the first hosted client on Empirica Trace
¨ Positive results from seventeen qualification inspections and client audits
¨ Participation in eleven regulatory health authority inspections conducted at client sites with no major findings

"Growing revenue 25 % is a great accomplishment for Sentrx," said Joseph Albano, Chief Executive Officer of Sentrx, "but I am most proud of our consistent record of compliance. As our client base grows, so does the level of scrutiny our people, processes and technology undergo. The regulatory audit results combined with our financial results demonstrate that Sentrx is the drug safety services provider that companies can rely on."

About Sentrx
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and post-approval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center in Little Falls, NJ, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please call 1-888-399-8032, extension 261; visit the Sentrx website at; or
view the Sentrx movie at


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
2. China Biologic Products Reports Strong Third Quarter 2008 Results
3. ACORN CRO Continues Growth in Strong Third Quarter
4. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
5. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
6. Shires New Product Portfolio Delivers Strong Quarterly Performance
7. Cephalon Reports Another Strong Quarter
8. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
9. Strong elasticity size effects in ZnO nanowires
10. Senetek Affirms Strong Financial Position
11. Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability
Post Your Comments:
(Date:10/8/2015)...  The ALS Association, in partnership with Prize4Life, is ... revolutionize communication technology solutions for people living with ALS. ... (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that ... spinal cord. Eventually, people with ALS lose the ability ... to total paralysis and death within two to five ...
(Date:10/8/2015)... ... ... Talon Innovations, a provider of Precision Machined Products and Assemblies ... one of three finalists for the Minnesota Business magazine’s Manufacturing Award in the category ... was recognized as a nominee for this competitive award. , The “Best in ...
(Date:10/7/2015)... , Oct. 7, 2015 Boston ... the start of the Boston Scientific Connected Patient ... advancements in the use of remote patient monitoring to ... designers and entrepreneurs can submit their ideas and collaborate ... ( ). Cambridge, MA ...
(Date:10/7/2015)... -- ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV ) ("ContraVir" or ... and commercialization of targeted antiviral therapies, today announced the ... of its common stock and warrants to purchase up ... a fixed combined price to the public of $3.00. ... issued separately.  The warrants will be exercisable for a ...
Breaking Biology Technology:
... , , HUNTSVILLE, Ala., ... in nucleic acid therapeutics and delivery, announced today that Jason ... Pharmacology to Vice-President of Preclinical Research and Development. , ... management and scientific leadership experience in the biotechnology industry and ...
... , , SAN MARINO, Calif., ... has formed a wholly owned subsidiary called MetaCytoLytics, Inc. This ... of Colorado Professor M. Karen Newell called "metabolic disruption technology" ... generate energy from glucose or from fatty acids. That ...
... , , PASADENA, Calif., Aug. 6 AutoImmune ... $86,000, or $0.01 per share basic and diluted, for the three ... $86,000, or $0.01 per share basic and diluted, for the three ... 30, 2009, the net loss was $256,000, or $0.02 per share ...
Cached Biology Technology:
(Date:9/10/2015)... 10, 2015 Report Details ... Selling Opportunities and Revenue Prospects to Help You ... biologics, especially new drug classes? Get the latest ... with exclusive market data and industry knowledge, benefitting ... results, opportunities and sales predictions. Visiongain,s new ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security ... and solution-based milestones, furthering the company,s commitment to ... online fraud. NuData Security,s online fraud ... the company,s growth cycle. The product combines continual ... determine good user behavior from fraudulent behavior, allowing ...
(Date:9/2/2015)... 2015 Security of data and assets ... government organizations, telecommunications, hospitals, as well as individuals. ... being used to prevent unauthorised access. Technological advancements ... individuals could gain access to secure premises after ... hardware devices and numeric codes. However, hackers also ...
Breaking Biology News(10 mins):
... for Medical Research have glimpsed two proteins working together ... nucleus and its exterior compartment, the cytoplasm. The research ... is found in organisms from yeast to humans does ... Investigator Sue Jaspersen, Ph.D., focused on a protein called ...
... at high elevations found in residents of the Tibetan ... related to contemporary Sherpa. These genes were passed on ... mixing, and then amplified by natural selection in the ... by scientists from the University of Chicago and Case ...
... that electrically stimulate the auditory nerve have granted ... people worldwide who otherwise would be totally deaf. Existing ... transmitter about an inch in diameter be affixed to ... joint microphone and power source that looks like an ...
Cached Biology News:
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... The GenElute Gel Extraction Kit combines silica- binding ... vacuum column format. DNA fragments of interest are ... solubilizing the gel. The Gel Solubilization Solution can ... in either TBE or TAE buffer. Extracted DNA ...
... are designed for the rapid purification of linear ... gels. The DNA band is excised from an,agarose ... within the base of the column are a ... and impurities back while allowing DNA to selectively ...
... Ultra Agarose Spin Kit is an advanced system for ... purified DNA can be used directly for any downstream ... DNA is ready to use in 56 minutes ... used for TAE and TBE gels No specialised ...
Biology Products: